Disc Medicine, Inc.
Disc Medicine, Inc. (IRON) Stock Overview
Explore Disc Medicine, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.1B
P/E Ratio
-17.35
EPS (TTM)
$-3.89
ROE
-0.23%
IRON Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Disc Medicine, Inc. (IRON) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 67.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $68.63.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.35 and a market capitalization of 2.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.